ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 120 filers reported holding ARCELLX INC in Q1 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,300,934 | +18.3% | 203,482 | +4.2% | 1.34% | +25.0% |
Q2 2023 | $6,174,121 | +35.7% | 195,260 | +32.2% | 1.07% | +8.2% |
Q1 2023 | $4,548,973 | +21.3% | 147,646 | +21.9% | 0.99% | -1.0% |
Q4 2022 | $3,751,461 | +42.9% | 121,093 | -13.4% | 1.00% | +33.9% |
Q3 2022 | $2,625,000 | -18.4% | 139,875 | -21.4% | 0.75% | -37.0% |
Q2 2022 | $3,218,000 | – | 178,000 | – | 1.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $169,455,216 | 63.12% |
NEA Management Company, LLC | 4,745,262 | $146,201,522 | 10.11% |
Samsara BioCapital, LLC | 909,579 | $28,024,129 | 5.79% |
Paradigm Biocapital Advisors LP | 1,757,779 | $54,157,171 | 5.13% |
Soleus Capital Management, L.P. | 1,248,147 | $38,455,409 | 3.98% |
Perceptive Advisors | 3,841,739 | $118,363,979 | 3.50% |
Cormorant Asset Management, LP | 1,600,000 | $49,296 | 3.25% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,398,321 | $73,892,270 | 3.12% |
Altium Capital Management LP | 150,000 | $4,621,500 | 2.56% |
Novo Holdings A/S | 1,225,000 | $37,742,250 | 2.49% |